These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 1724038)

  • 21. The different effects of recombinant human interferon-gamma and recombinant human interferon-beta on the activation of natural killer cells.
    Okabe M; Gomi K; Morimoto M; Nakamizo N
    Jpn J Cancer Res; 1985 Jul; 76(7):608-17. PubMed ID: 3928557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross-reaction of a rat-anti-mouse phagocyte-specific monoclonal antibody (anti-Mac-1) with human monocytes and natural killer cells.
    Ault KA; Springer TA
    J Immunol; 1981 Jan; 126(1):359-64. PubMed ID: 7451976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization and utilization of a monoclonal antibody inhibiting porcine natural killer cell activity for isolation of natural killer and killer cells.
    Dato ME; Kim YB
    J Immunol; 1990 Jun; 144(11):4452-62. PubMed ID: 1971298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting of cytotoxic cells against tumors with heterocrosslinked, bispecific antibodies.
    Segal DM; Qian JH; Garrido MA; Perez P; Winkler DF; Wunderlich JR; Snider DP; Valdayo MJ; Titus JA
    Princess Takamatsu Symp; 1988; 19():323-31. PubMed ID: 3269363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Suitability of a clinical practice method of evaluating the activity of natural and antibody-dependent killer cells].
    Gordienko SM
    Lab Delo; 1983; (9):45-8. PubMed ID: 6195439
    [No Abstract]   [Full Text] [Related]  

  • 26. Antibody-mediated killing of human tumor cells by attached effector cells.
    Hellström I; Garrigues U; Lavie E; Hellström KE
    Cancer Res; 1988 Feb; 48(3):624-7. PubMed ID: 3335025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
    Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
    J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of antibody-dependent natural killer cell-mediated AK-5 tumor cell death.
    Kausalya S; Hegde SP; Bright JJ; Khar A
    Exp Cell Res; 1994 Jun; 212(2):285-90. PubMed ID: 8187821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripheral blood granulocytes as effectors of regulation for the human natural killer cell system. A review.
    Kay HD; Klassen LW
    Nat Immun Cell Growth Regul; 1986; 5(1):1-18. PubMed ID: 3517627
    [No Abstract]   [Full Text] [Related]  

  • 30. [A method of determining the antibody-dependent cytotoxicity of lymphocytes in man].
    Zheleznikova GF; Gnilevskaia ZU
    Lab Delo; 1988; (1):33-5. PubMed ID: 2451071
    [No Abstract]   [Full Text] [Related]  

  • 31. Natural killer and antibody-dependent cytotoxicity following thermal injury in humans.
    Antonacci AC; Gupta S; Good RA; Shires GT; Fernandes G
    Curr Surg; 1983; 40(1):20-3. PubMed ID: 6600996
    [No Abstract]   [Full Text] [Related]  

  • 32. Modulation of natural cytotoxicity by alloantibodies: part II--Effect of anti HLA antisera on the natural killer activity of human peripheral blood leukocytes against a human & a murine cell line.
    Saxena RK; Spees EK; Adler WH
    Indian J Exp Biol; 1981 Jul; 19(7):595-7. PubMed ID: 7309145
    [No Abstract]   [Full Text] [Related]  

  • 33. A comparison of membrane markers on rat cytotoxic cells.
    Cantrell DA; Robins RA; Baldwin RW
    Immunology; 1983 May; 49(1):139-46. PubMed ID: 6220963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Membrane markers, target cell specificity, and sensitivity to biological response modifiers distinguish human natural cytotoxic from human natural killer cells.
    Rola-Pleszczynski M; Lieu H; Sullivan AK; Girard M
    J Clin Invest; 1985 Nov; 76(5):1927-31. PubMed ID: 2932473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1.
    Perussia B; Starr S; Abraham S; Fanning V; Trinchieri G
    J Immunol; 1983 May; 130(5):2133-41. PubMed ID: 6833758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The role of the killer activity of the peripheral blood lymphocytes in the pathogenesis of rheumatism].
    Dubkova AG; Gandzha IM; Guseva SA; Vozniuk VP
    Lik Sprava; 1997; (1):39-42. PubMed ID: 9221141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immune reaction in monkeys to single and fractionated low-dose gamma-irradiation].
    Sambur MB; Melńikov OF; Timchenko SV; Sidorenko TV; Barkaia VS; Onishchuk FD
    Radiats Biol Radioecol; 1993; 33(5):706-13. PubMed ID: 8293097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Understanding natural killer cells.
    Beverley P
    Nature; 1981 May; 291(5813):288. PubMed ID: 7231548
    [No Abstract]   [Full Text] [Related]  

  • 39. 21st century natural killers.
    Tato CM
    Nat Rev Immunol; 2019 Feb; 19(2):69. PubMed ID: 30626905
    [No Abstract]   [Full Text] [Related]  

  • 40. Natural killers join the fight against cancer.
    Cerwenka A; Lanier LL
    Science; 2018 Mar; 359(6383):1460-1461. PubMed ID: 29599226
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.